RHBC
R.H. Bluestein & Co’s Eli Lilly LLY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $35.3M | Buy |
109,022
+45,038
| +70% | +$14.6M | 2.19% | 14 |
|
2022
Q2 | $20.7M | Buy |
+63,984
| New | +$20.7M | 1.27% | 22 |
|
2019
Q4 | – | Sell |
-233,919
| Closed | -$26.2M | – | 354 |
|
2019
Q3 | $26.2M | Buy |
233,919
+3,909
| +2% | +$437K | 1.47% | 33 |
|
2019
Q2 | $25.5M | Buy |
230,010
+18,359
| +9% | +$2.03M | 1.36% | 35 |
|
2019
Q1 | $27.5M | Buy |
211,651
+144,669
| +216% | +$18.8M | 1.5% | 28 |
|
2018
Q4 | $7.75M | Buy |
+66,982
| New | +$7.75M | 0.61% | 38 |
|
2016
Q4 | – | Sell |
-5,595
| Closed | -$449K | – | 315 |
|
2016
Q3 | $449K | Sell |
5,595
-27,180
| -83% | -$2.18M | 0.03% | 121 |
|
2016
Q2 | $2.58M | Buy |
+32,775
| New | +$2.58M | 0.2% | 41 |
|
2014
Q3 | – | Sell |
-7,550
| Closed | -$469K | – | 372 |
|
2014
Q2 | $469K | Sell |
7,550
-450
| -6% | -$28K | 0.03% | 217 |
|
2014
Q1 | $471K | Buy |
+8,000
| New | +$471K | 0.03% | 198 |
|